David Soong

1.3k total citations
9 papers, 115 citations indexed

About

David Soong is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, David Soong has authored 9 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in David Soong's work include Multiple Myeloma Research and Treatments (7 papers), Cancer Genomics and Diagnostics (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). David Soong is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Cancer Genomics and Diagnostics (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). David Soong collaborates with scholars based in United States, Italy and Australia. David Soong's co-authors include John Thompson, Rebecka S. Hess, J.R. Poley, Christopher Chiu, Nizar J. Bahlis, Hervé Avet‐Loiseau, Jordan M. Schecter, Ming Qi, Blerta Stringa and Jesús F. San Miguel and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

David Soong

9 papers receiving 105 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Soong United States 6 42 32 30 21 21 9 115
Marianna Romžová Czechia 7 59 1.4× 12 0.4× 16 0.5× 10 0.5× 4 0.2× 14 148
M. Baltaci Austria 5 37 0.9× 10 0.3× 43 1.4× 27 1.3× 21 1.0× 9 125
Mahdi Jahantigh Iran 6 83 2.0× 8 0.3× 24 0.8× 5 0.2× 8 0.4× 9 190
M Gergely United States 6 20 0.5× 9 0.3× 8 0.3× 13 0.6× 5 0.2× 18 92
Debora Parracciani Italy 5 33 0.8× 30 0.9× 32 1.1× 5 0.2× 3 0.1× 6 157
Rebecca McCann United Kingdom 8 52 1.2× 5 0.2× 102 3.4× 28 1.3× 4 0.2× 9 179
Francesca Pezzetta Italy 7 10 0.2× 16 0.5× 19 0.6× 3 0.1× 14 0.7× 15 84
Claudia Hirschi Switzerland 4 32 0.8× 5 0.2× 13 0.4× 6 0.3× 4 0.2× 5 101
Jennifer Dolgoff United States 4 86 2.0× 6 0.2× 138 4.6× 26 1.2× 4 0.2× 4 264
Gillian Bromfield Canada 3 53 1.3× 5 0.2× 37 1.2× 27 1.3× 2 0.1× 4 139

Countries citing papers authored by David Soong

Since Specialization
Citations

This map shows the geographic impact of David Soong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Soong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Soong more than expected).

Fields of papers citing papers by David Soong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Soong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Soong. The network helps show where David Soong may publish in the future.

Co-authorship network of co-authors of David Soong

This figure shows the co-authorship network connecting the top 25 collaborators of David Soong. A scholar is included among the top collaborators of David Soong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Soong. David Soong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Soong, David, Jeran K. Stratford, Hervé Avet‐Loiseau, et al.. (2020). CNV Radar: an improved method for somatic copy number alteration characterization in oncology. BMC Bioinformatics. 21(1). 98–98. 11 indexed citations
2.
Weisel, Katja, Andrew Spencer, Suzanne Lentzsch, et al.. (2019). Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk: Updated subgroup analysis of CASTOR.. Journal of Clinical Oncology. 37(15_suppl). 8040–8040. 1 indexed citations
3.
Kaufman, Jonathan L., Meletios Α. Dimopoulos, Merav Leiba, et al.. (2019). Efficacy and safety of daratumumab, lenalidomide, and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Updated subgroup analysis of POLLUX based on cytogenetic risk.. Journal of Clinical Oncology. 37(15_suppl). 8038–8038. 5 indexed citations
4.
Romanel, Alessandro, Sonia Garritano, Blerta Stringa, et al.. (2017). Inherited determinants of early recurrent somatic mutations in prostate cancer. Nature Communications. 8(1). 48–48. 23 indexed citations
5.
Weisel, Katja, Jesús F. San Miguel, Gordon Cook, et al.. (2017). Efficacy of daratumumab in combination with lenalidomide plus dexamethasone (DRd) or bortezomib plus dexamethasone (DVd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk status.. Journal of Clinical Oncology. 35(15_suppl). 8006–8006. 16 indexed citations
6.
Neri, Paola, Ranjan Maity, Caleb K. Stein, et al.. (2017). Transcriptional Plasticity Compensates for Ikaros and Aiolos Proteasomal Degradation and Mediates Resistance to IMiDs in Multiple Myeloma (MM). Blood. 130(Suppl_1). 63–63. 5 indexed citations
7.
Mateos, María‐Victoria, Andrew Spencer, Ajay K. Nooka, et al.. (2017). Safety and efficacy of daratumumab-based regimens in elderly (≥75 y) patients (Pts) with relapsed or refractory multiple myeloma (RRMM): Subgroup analysis of POLLUX and CASTOR.. Journal of Clinical Oncology. 35(15_suppl). 8033–8033. 3 indexed citations
8.
Spencer, Andrew, Tomer M. Mark, Ivan Špıčka, et al.. (2017). Depth of Response and MRD with Daratumumab Plus Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in RRMM: CASTOR. Clinical Lymphoma Myeloma & Leukemia. 17(1). e85–e85. 2 indexed citations
9.
Soong, David, John Thompson, J.R. Poley, & Rebecka S. Hess. (1972). Hydroxy Fatty Acids in Human Diarrhea. Gastroenterology. 63(5). 748–757. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026